Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.

747 indexed citations
published 1991

Countries where authors are citing Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.

Specialization
Citations

This map shows the geographic impact of Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. more than expected).

Fields of papers citing Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis..

About Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.

This paper, published in 1991, received 747 indexed citations . Written by David S. Askew, Richard A. Ashmun and John L. Cleveland. It is primarily cited by scholars working on Molecular Biology (555 citations), Oncology (335 citations) and Immunology (138 citations). Published in PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w63435382.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026